Innovative Strategies to Abolish Microbial Persistence in Biofilm Fortresses
Biomolecules · 16.06.2026 · 16 (6) · 887
DOI: 10.3390/biom16060887 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 16.06.2026. Verfasst von Diana-Antonia Costea und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, University of Bucharest, Splaiul Independentei 91-95, R-050095 Bucharest, Romania. Hauptthemen laut MEDLINE: Biofilms, Anti-Bacterial Agents, Anti-Infective Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 312 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Biofilms are structured communities of microorganisms embedded in a self-produced extracellular polymeric substance (EPS) matrix, whose development significantly enhances microbial resistance to antibiotics, disinfectants, and host immune defenses, posing major challenges in clinical, industrial, and environmental settings. Compared with planktonic cells, biofilm-associated microorganisms can exhibit up to 10- to 1000-fold increased tolerance to antimicrobial agents, contributing to the persistence of biofilm-associated infections (BAIs). These infections remain difficult to eradicate due to reduced penetration, altered metabolic states, and the presence of dormant or persister cells. Anti-biofilm strategies can be broadly classified into physical approaches (e.g., ultrasound, mechanical stress, and light-based approaches) that target biofilm structure; chemical and enzymatic methods (e.g., EPS-degrading enzymes) that destabilize the matrix; and biological and molecular strategies (e.g., quorum-sensing (QS) inhibitors, anti-virulence agents, bacteriophages, phage-derived antimicrobial molecules, antimicrobial peptides, and natural bioactive compounds) that modulate biofilm development and integrity by targeting regulatory pathways and matrix stability through distinct mechanisms of action. Natural compounds, including lactoferrin, lactoferrin-derived peptides, and probiotic and postbiotic fractions of lactic acid bacteria (LAB), as well as plant-derived metabolites, have shown promising anti-biofilm effects, with efficacy often enhanced through complementary or potentially synergistic interactions. However, despite these advancements, clinical translation remains limited. For example, BAIs account for approximately 80% of chronic infections, with high recurrence rates and therapeutic failure reported in device-associated infections and chronic wounds. These limitations highlight the need for clinically translatable, multimodal approaches that integrate structural biofilm disruption, antimicrobial targeting, and host response modulation to design more effective and sustainable anti-biofilm strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Biology, University of Bucharest, Splaiul Independentei 91-95, R-050095 Bucharest, Romania.
- Doctoral School of Urban Planning, "Ion Mincu" University of Architecture and Urbanism, Academiei Street 18-20, R-010014 Bucharest, Romania.
ORCID-Profile: Diana-Antonia Costea, Valentina-Alexandra Badaluta, Ioana Zachia-Zlatea, Lia-Mara Ditu
Zitieren
APA
Costea, D. A., Badaluta, V. A., Zachia-Zlatea, I., Holban, A. M., Ditu, L. M., & Lazar, V. (2026). Innovative Strategies to Abolish Microbial Persistence in Biofilm Fortresses. Biomolecules, 16(6), 887. https://doi.org/10.3390/biom16060887
Vancouver
Costea DA, Badaluta VA, Zachia-Zlatea I, Holban AM, Ditu LM, Lazar V. Innovative Strategies to Abolish Microbial Persistence in Biofilm Fortresses. Biomolecules. 2026;16(6):887. doi:10.3390/biom16060887
BibTeX
@article{Costea2026,
author = {Costea, Diana-Antonia and Badaluta, Valentina-Alexandra and Zachia-Zlatea, Ioana and Holban, Alina-Maria and Ditu, Lia-Mara and Lazar, Veronica},
title = {Innovative Strategies to Abolish Microbial Persistence in Biofilm Fortresses},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {887},
doi = {10.3390/biom16060887}
}
EUVIMED